Infectious Neurology
Herpes Simplex Encephalitis
Herpes simplex encephalitis requires immediate recognition and IV acyclovir while cerebrospinal fluid HSV PCR establishes the diagnosis. Renal-adjusted dosing, hydration, and surveillance for virologic versus autoimmune relapse are the highest-yield management decisions supported by the available evidence.
Diagnosis
Confirm HSV CNS infection with CSF PCR
Obtain CSF for HSV PCR promptly when HSE is suspected.
Detection of HSV DNA in CSF by polymerase chain reaction is the diagnostic gold standard for herpes simplex encephalitis and has supplanted brain biopsy. Wolters KluwerWolters KluwerHerpes Simplex Virus Infections of the Central Nervous System In reported HSE cases, MRI abnormalities involving medial temporal and hippocampal regions have accompanied CSF HSV-1 PCR positivity. Wolters KluwerWolters KluwerCIDSCON 2023 Selected Abstracts
CSF results can be inflammatory but are not independently diagnostic. A reported confirmed case had 22 CSF leukocytes, markedly elevated protein of 250 mg/dL, and opening pressure of 39 cm H2O before HSV PCR returned positive. accessdata fdaaccessdata fdacenter for drug evaluation and research - accessdata.fda.gov Do not use a nonspecific CSF profile to defer HSV PCR or antiviral treatment when the clinical syndrome remains concerning.
Order CSF HSV PCR as the virologic diagnostic test when evaluating suspected HSE. Wolters KluwerWolters KluwerHerpes Simplex Virus Infections of the Central Nervous System
Use brain MRI and EEG as complementary assessments when clinically indicated; published HSE reports describe temporal-limbic MRI abnormalities and electroencephalographic slowing. Wolters KluwerWolters KluwerCIDSCON 2023 Selected Abstracts
Interpret a later clinical relapse with repeat CSF HSV PCR and evaluation for neural autoantibodies when the phenotype is compatible with autoimmune encephalitis. PubMed+1PubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
Treatment
Initiate and safely deliver IV acyclovir
Acyclovir is the supported antiviral regimen in the supplied guidance.
NIH opportunistic-infection guidance lists acyclovir 10 mg/kg IV every 8 hours for HSV encephalitis for 14-21 days. The same guidance notes that some clinicians extend treatment according to clinical response and degree of immunosuppression. clinicalinfo hivclinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIH The available excerpts do not support a routine oral step-down regimen for HSE.
Renal toxicity prevention and dose adjustment are integral to administration. Give IV fluids with IV acyclovir to reduce nephrotoxicity risk. Monitor renal function at treatment initiation and at least once or twice weekly during treatment when stable; adjust dosing for renal function. clinicalinfo hiv+2clinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIHclinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
Standard regimen: acyclovir 10 mg/kg IV every 8 hours for HSV encephalitis, for 14-21 days. clinicalinfo hivclinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIH
Use IV hydration during IV acyclovir therapy to reduce nephrotoxicity risk. clinicalinfo hiv+1clinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
Assess renal function at initiation and at least once or twice weekly during high-dose IV acyclovir therapy if stable. clinicalinfo hiv+1clinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIHclinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...
For intermittent hemodialysis, administer the adjusted acyclovir dose after dialysis on dialysis days. clinicalinfo hiv+1clinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
Complications
Evaluate post-HSE deterioration for viral or autoimmune relapse
Relapse is not synonymous with recurrent HSV replication.
Published series and reviews estimate HSE relapse after an initial episode at approximately 5%-27%; one case-series report cites relapse in up to 12% of adults and 14%-35% of children despite antiviral therapy. PubMed+1PubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC These estimates are derived from observational literature and should not be treated as a precise individual risk prediction.
A true virologic relapse is suggested by HSV DNA detection in CSF and may be accompanied by new necrotic or hemorrhagic lesions on brain imaging. PubMedPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC In contrast, post-HSE autoimmune relapse often has negative CSF HSV PCR and may reflect immune responses to CNS antigens exposed by HSV-related injury. PubMed+1PubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
In a post-HSE case series, serum and CSF were tested for anti-NMDAR, GABA-B receptor, AMPAR, LGI1, CASPR2, and DPPX antibodies. PubMedPubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMC The available evidence supports targeted evaluation for autoimmune encephalitis in a compatible relapse syndrome but does not provide an adult U.S. immunotherapy regimen. Pediatric consensus guidance states that NMDA receptor antibody encephalitis following HSE should be treated similarly to idiopathic NMDA receptor antibody encephalitis. NeurologyNeurologyInternational Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis
Reassess CSF HSV PCR in a suspected recurrence to identify persistent or recurrent HSV replication. PubMedPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
If HSV PCR is negative and relapse features suggest autoimmune encephalitis, send paired serum and CSF neural antibody testing where available. PubMedPubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMC
Consider post-HSE autoimmune encephalitis particularly with new agitation, movement disorder, seizures, cognitive change, or psychiatric manifestations after the acute infection. Wolters Kluwer+2Wolters KluwerCIDSCON 2023 Selected AbstractsPubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
Involve neurology and infectious diseases when deciding whether deterioration represents viral relapse, autoimmune disease, or both; the supplied evidence does not establish a universal treatment pathway.
Adjunctive corticosteroids
The supplied search results identify a systematic review addressing adjunctive corticosteroids in HSE but do not provide recommendations, effect estimates, or a validated dexamethasone regimen. The LancetThe LancetSafety and efficacy of adjunct dexamethasone in adults ... Routine corticosteroid use therefore cannot be recommended or operationalized from the available evidence.
Monitoring
Monitor renal safety and neurologic trajectory
Treatment monitoring should focus on acyclovir exposure safety and new neurologic deterioration.
For high-dose IV acyclovir, renal function monitoring and renal dose adjustment are specifically recommended at treatment initiation and once or twice weekly during therapy when stable. clinicalinfo hiv+1clinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIHclinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ... Hydration is recommended to reduce acyclovir-associated nephrotoxicity. clinicalinfo hiv+1clinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
After acute HSE, counsel patients and caregivers that relapse can occur despite antiviral therapy. PubMed+1PubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC New neurologic, behavioral, cognitive, movement, or seizure manifestations should trigger reassessment for recurrent HSV and postinfectious autoimmune encephalitis rather than automatic attribution to fixed post-encephalitic deficits. Wolters Kluwer+2Wolters KluwerCIDSCON 2023 Selected AbstractsPubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
At initiation: document renal function and select the renal-adjusted IV acyclovir schedule. clinicalinfo hiv+1clinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
During therapy: monitor renal function at least once or twice weekly if stable and revise dosing when renal function changes. clinicalinfo hiv+1clinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIHclinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...
After treatment: investigate meaningful clinical deterioration with repeat CSF HSV PCR and, when indicated, neural antibody testing. PubMed+1PubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
Common questions
What is the preferred diagnostic test for herpes simplex encephalitis?
CSF HSV DNA PCR is the diagnostic gold standard and has replaced brain biopsy for usual HSE diagnosis. Wolters KluwerWolters KluwerHerpes Simplex Virus Infections of the Central Nervous System
What acyclovir regimen is used for HSV encephalitis?
The supplied NIH guidance lists acyclovir 10 mg/kg IV every 8 hours for 14-21 days, with possible extension based on clinical response and immunosuppression. clinicalinfo hivclinicalinfo hivHerpes Simplex Virus: Adult and Adolescent OIs | NIH
How should IV acyclovir be adjusted in renal impairment?
For HSV encephalitis, use the full dose every 12 hours at CrCl/eGFR 26-50 mL/min, every 24 hours at 10-25 mL/min, and 50% of the dose every 24 hours at less than 10 mL/min or on hemodialysis; dose after hemodialysis. clinicalinfo hiv+1clinicalinfo hivGuidelines for the Prevention and Treatment of Opportunistic ...clinicalinfo hivTables: Recommended Dosing Adjustments of Drugs Used ...
What should prompt evaluation for autoimmune encephalitis after HSE?
A new neuropsychiatric, cognitive, seizure, or movement-disorder syndrome after HSE, particularly with negative repeat CSF HSV PCR, should prompt evaluation for post-HSE autoimmune encephalitis and neural antibodies. Wolters Kluwer+2Wolters KluwerCIDSCON 2023 Selected AbstractsPubMedPostherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMCPubMedImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC
References
- center for drug evaluation and research - accessdata.fda.gov — www.accessdata.fda.gov · www.accessdata.fda.gov
- Safety and efficacy of adjunct dexamethasone in adults ... — www.thelancet.com · www.thelancet.com
- Supplementary appendix — www.thelancet.com · www.thelancet.com
- Herpes Simplex Virus Infections of the Central Nervous System — journals.lww.com · journals.lww.com
- 616: HERPES SIMPLEX VIRUS ENCEPHALITIS WITH... — journals.lww.com · journals.lww.com
- Herpes Simplex Virus Meningoencephalitis in a Patient ... — journals.lww.com · journals.lww.com
- CIDSCON 2023 Selected Abstracts — journals.lww.com · journals.lww.com
- Autoimmune encephalitis after herpes simplex ... — www.sciencedirect.com · www.sciencedirect.com
- Clinical phenotype and outcomes in autoimmune ... — www.sciencedirect.com · www.sciencedirect.com
- International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis — www.neurology.org · www.neurology.org
- Clinical Characteristics, Treatment Patterns, and Outcomes ... — www.neurology.org · www.neurology.org
- A case report and systematic review of the literature (P6.093) — www.neurology.org · www.neurology.org
- A Rare Case of Herpes Simplex Virus Type 2 Encephalitis ... — www.neurology.org · www.neurology.org
- Herpes Simplex Virus Encephalitis During Suppressive ... — publications.aap.org · publications.aap.org
- Brainstem Involvement in Neonatal Herpes Simplex Virus ... — publications.aap.org · publications.aap.org
- Herpes Simplex Virus Central Nervous System Relapse ... — publications.aap.org · publications.aap.org
- Early Diagnosis of Herpes Simplex Encephalitis — publications.aap.org · publications.aap.org
- Management of Central Nervous System Infections, Vientiane, ... — wwwnc.cdc.gov · wwwnc.cdc.gov
- Herpes Simplex Virus: Adult and Adolescent OIs | NIH — clinicalinfo.hiv.gov · clinicalinfo.hiv.gov
- Guidelines for the Prevention and Treatment of Opportunistic ... — clinicalinfo.hiv.gov · clinicalinfo.hiv.gov
- Tables: Recommended Dosing Adjustments of Drugs Used ... — clinicalinfo.hiv.gov · clinicalinfo.hiv.gov
- Adult and Adolescent Opportunistic Infection Guidelines — clinicalinfo.hiv.gov · clinicalinfo.hiv.gov
- Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov